The markets closed mixed with the Dow rising 22 points to 17,251 as the Federal Reserve meets. Nasdaq dropped 21 points to 4,728.
On the upside
Fourth quarter earnings and revenue surged for Inogen (Nasdaq: INGN) to surpass analyst expectations and the company forecast full year revenue ahead of estimates.
Bargain hunters lifted shares of Vericel (Nasdaq: VCEL).
Outerwall (Nasdaq: OUTR) doubled its quarterly dividend and announced plans to explore strategic alternatives to maximize shareholder value.
On the downside
Shares of Endo International (Nasdaq: ENDP) plummeted in reaction to Valeant's (Nasdaq: VRX) disappointing results.
Investors locked in profits on Zynerba Pharmaceuticals (Nasdaq: ZYNE).
Aralez Pharmaceuticals (Nasdaq: ARLZ) fell to a loss for the fourth quarter.
In the broad market, declining issues outpaced advancers by a margin of nearly 3 to 1 on the NYSE and by more than 3 to 1 on Nasdaq. The broader S&P 500 slipped 3 points to 2,015. Bitcoin added $1 to $415.
